MDM2 binds TP53

Stable Identifier
Reaction [binding]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The N-terminal portion of MDM2 binds the N-terminal transactivation domain of TP53 (p53) and inhibits transcriptional transactivation by TP53 (Momand et al. 1992, Oliner et al. 1992, Oliner et al. 1993, Chen et al. 1993).
Literature References
PubMed ID Title Journal Year
1614537 Amplification of a gene encoding a p53-associated protein in human sarcomas

Meltzer, PS, Vogelstein, B, George, DL, Kinzler, KW, Oliner, JD

Nature 1992
21986495 Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage

Chen, L, Chen, J, Cheng, Q, Li, B, Cross, B, Li, Z

Mol. Cell. Biol. 2011
14507994 HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

Linares, LK, Scheffner, M, Hengstermann, A, Muller, S, Ciechanover, A

Proc. Natl. Acad. Sci. U.S.A. 2003
7686617 Mapping of the p53 and mdm-2 interaction domains

Levine, AJ, Chen, J, Marechal, V

Mol. Cell. Biol. 1993
1535557 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Levine, AJ, Olson, DC, Zambetti, GP, George, D, Momand, J

Cell 1992
8479525 Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Gyuris, J, Vogelstein, B, Pietenpol, JA, Kinzler, KW, Oliner, JD, Thiagalingam, S

Nature 1993
This event is regulated
Negatively by
Orthologous Events
Cite Us!